CurrentEndo
Get Weekly

Topic · page 100 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 3,961–4,000 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Res Clin Pract

    Lower free triiodothyronine levels are associated with higher all-cause and cardiovascular mortality in people with diabetes-NHANES 2007–2012

    Cohort study

  2. Diabetes Care

    Effect of Early Glycemic Control in Youth-Onset Type 2 Diabetes on Longer-Term Glycemic Control and β-Cell Function: Results From the TODAY Study

    Secondary analysis

  3. Cardiovasc Diabetol

    Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis study

    Meta-analysis

  4. Cardiovasc Diabetol

    Incremental effect of coronary obstruction on myocardial microvascular dysfunction in type 2 diabetes mellitus patients evaluated by first-pass perfusion CMR study

    Cross-sectional study

  5. Cardiovasc Diabetol

    Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin

    Secondary analysis

  6. J Diabetes Sci Technol

    Development and Validation of an Electronic Health Record–Based Risk Assessment Tool for Hypoglycemia in Patients With Type 2 Diabetes Mellitus

    Diagnostic or prognostic study

  7. J Clin Endocrinol Metab

    Dose-dependent Association of Alcohol Consumption With Obesity and Type 2 Diabetes: Mendelian Randomization Analyses

    Research article

  8. Obesity (Silver Spring)

    BMI, insulin sensitivity, and cognition in early type 2 diabetes: The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study

    Cross-sectional study

  9. Diabetes Care

    Relationship Among Diabetes, Obesity, and Cardiovascular Disease Phenotypes: A UK Biobank Cohort Study

    Cohort study

  10. Lancet

    Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

    Randomized controlled trial

  11. Cardiovasc Diabetol

    Independent and joint associations between the triglyceride-glucose index and NT-proBNP with the risk of adverse cardiovascular events in patients with diabetes and acute coronary syndrome: a prospective cohort study

    Cohort study

  12. Cardiovasc Diabetol

    Prognostic impacts of diabetes status and lipoprotein(a) levels in patients with ST-segment elevation myocardial infarction: a prospective cohort study

    Cohort study

  13. Cardiovasc Diabetol

    Rapid kidney function decline and increased risk of heart failure in patients with type 2 diabetes: findings from the ACCORD cohort : Rapid kidney function decline and heart failure in T2D

    Secondary analysis

  14. Lancet

    Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial

    Randomized controlled trial

  15. Diabetes Res Clin Pract

    Effects of combined treatment of probiotics and metformin in management of type 2 diabetes: A systematic review and meta-analysis

    Meta-analysis

  16. N Engl J Med

    Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin

    Randomized controlled trial

  17. Diabetes Res Clin Pract

    DNA methylation partially mediates antidiabetic effects of metformin on HbA1c levels in individuals with type 2 diabetes

    Mechanistic study

  18. Diabetes Res Clin Pract

    Re-evaluation of dipeptidyl peptidase-4 inhibitors in patients with heart failure and diabetes mellitus

    Meta-analysis

  19. Lancet

    Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study

    Randomized controlled trial

  20. Diabetes Care

    Type 2 Diabetes Polygenic Score Predicts the Risk of Glucocorticoid-Induced Hyperglycemia in Patients Without Diabetes

    Cohort study

  21. Diabetes Obes Metab

    Association between glycaemia risk index ( GRI ) and diabetic retinopathy in type 2 diabetes: A cohort study

    Cohort study

  22. J Clin Endocrinol Metab

    Association of Body Mass Index and Its Change With Incident Diabetes Mellitus

    Cohort study

  23. Cardiovasc Diabetol

    Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetes

    Cohort study

  24. J Diabetes Sci Technol

    Delivering Biopsychosocial Health Care Within Routine Care: Spotlight-AQ Pivotal Multicenter Randomized Controlled Trial Results

    Randomized controlled trial

  25. Lancet

    Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial

    Randomized controlled trial

  26. Cardiovasc Diabetol

    Differential expression of coagulation pathway-related proteins in diabetic urine exosomes

    Mechanistic study

  27. Cardiovasc Diabetol

    Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial

    Randomized controlled trial

  28. Lancet Diabetes Endocrinol

    Disparities in diabetes prevalence and management by race and ethnicity in the USA: defining a path forward

    Research article

  29. Lancet

    Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

    Research article

  30. BMJ Open Diabetes Res Care

    Subsidised housing and diabetes mortality: a retrospective cohort study of 10 million low-income adults in Brazil

    Cohort study

  31. Diabetes Care

    Dulaglutide and Kidney Function–Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis

    Secondary analysis

  32. Diabetes Obes Metab

    Association of socioeconomic deprivation with sleep health in patients with type 2 diabetes

    Cross-sectional study

  33. Diabet Med

    Burden of undiagnosed and suboptimally controlled diabetes in selected regions of India: Results from the SMART India population‐level diabetes screening study

    Cross-sectional study

  34. Diabetes Obes Metab

    Orforglipron ( LY3502970 ), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1a, blinded, placebo‐controlled, randomized, single‐ and multiple‐ascending‐dose study in healthy participants

    Randomized controlled trial

  35. Diabetes Obes Metab

    Trends and disparities in telehealth use among Louisiana Medicaid beneficiaries with type 2 diabetes

    Cohort study

  36. Diabetes Care

    Metformin for Treatment of Acute COVID-19: Systematic Review of Clinical Trial Data Against SARS-CoV-2

    Meta-analysis

  37. Diabetologia

    How amenable is type 2 diabetes treatment for precision diabetology? A meta-regression of glycaemic control data from 174 randomised trials

    Randomized controlled trial

  38. J Diabetes Sci Technol

    Examining a Diabetes Self-Management Education and Support Telemedicine Model With High-Risk Patients in a Rural Community

    Cohort study

  39. Diabetes Obes Metab

    Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study

    Randomized controlled trial

  40. Diabet Med

    Copenhagen Diabetes Consensus (CODIAC) 2021: User involvement in diabetes care, prevention and research

    Guideline or statement

All 4,758 Briefs in ExploreShowing Briefs 3,961–4,000 of 4,758, newest first